Sergey Brin's autism research network has committed more than $450 million, The Transmitter reports

Aligning Research to Impact Autism (ARIA), the research network the Sergey Brin Family Foundation launched in 2024, has publicly committed more than $450 million to autism research, The Transmitter reported on October 13. About $300 million of that has been announced since June, a sum the publication says rivals the National Institutes of Health's annual budget for autism research.

Where the money is going

ARIA aims to speed research into profound autism and possible therapies. According to The Transmitter, its work is organized into six hubs. Five focus on biology: protein-protein interactions, human developmental neurobiology, genetic medicines, neurosensing and neuromodulation, and functional communication. The sixth, the IMPACT Network, links 20 hospitals and universities running clinical trials.

Two of the largest recent grants are $46 million each. One went to the University of California, San Francisco's Quantitative Biosciences Institute for the Protein-Protein Interactions Hub; UCSF announced it on August 27. The other went to Harvard University and Yale University for four projects in the Human Developmental Neurobiology Hub, The Transmitter reported. Ekemini Riley is ARIA's managing director.

How it compares

For scale, The Transmitter noted that the Simons Foundation Autism Research Initiative has an annual budget of about $100 million and has contributed roughly $750 million to $760 million since 2006. ARIA has passed $450 million since its 2024 launch.

Helen Tager-Flusberg, director of the Center for Autism Research Excellence at Boston University, told the publication, "The scope, integration and size of ARIA is very different from anything that NIH has or could mount." She also noted that federal research funding has become increasingly uncertain. Riley said of the commitments so far, "this is just the beginning."

Nevan Krogan, director of the UCSF institute, said in the university's announcement that "ARIA's commitment does exactly that. It accelerates our ability to move from molecular insight to therapeutic impact for autism and ultimately for many other diseases."

What donors and nonprofits can take from it

In our view, the notable choice is the structure: linked research hubs rather than one-off grants, each with a defined scientific question and lead institutions. It resembles other founder-led science philanthropy, such as Biohub's open biology data push, in betting that shared infrastructure moves a field faster than scattered awards.

ARIA describes itself as a research network, and neither source describes funding for direct services. Local autism service providers and family support groups should not read the total as a new source of program grants. They may find it useful in conversations with their own donors about where research money is, and is not, flowing.